Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
434.00
941.00
-530.00
1,079.00
412.00
1,232.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
691.00
1,253.00
-622.00
-2,639.00
-1,153.00
-1,162.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,877.00
2,695.00
520.00
-722.00
701.00
127.00
Cash Flow from Investing Activities
-1,012.00
-807.00
1,261.00
133.00
158.00
-2,528.00
Cash Flow from Financing Activities
-1,140.00
-2,278.00
-1,329.00
383.00
-603.00
2,816.00
Net Cash Inflow / Outflow
-253.00
-372.00
492.00
-185.00
180.00
285.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
22.00
18.00
40.00
20.00
-75.00
-130.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
434.566795180133
-979.518177586086
1,413.00
144.37%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
691.961521214651
-192.34347810797
883.00
459.75%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1877.57335151288
-318.873484752079
2,195.00
688.81%
Cash Flow from Investing Activities
-1012.89184872432
-1.68705229893688
-1,011.00
-59939.15%
Cash Flow from Financing Activities
-1140.54692603368
-266.168279544096
-874.00
-328.51%
Net Cash Inflow / Outflow
-253.044974576106
-584.347861036971
331.00
56.70%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
22.8204486690208
2.38095555813971
20.00
858.46%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -30.34% vs 417.43% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
1,877.57
2,695.21
-30.34%






